Learn aboutcost-savings, clinical use, and safety of biosimilars. Biosimilars by reference product(or byapproval date) Actemra(tocilizumab) Biosimilars NameRegulatory DesignationCompany NameFDA Approved Tyenne (tocilizumab-aazg)BiosimilarFresenius Kabi USA, LLCMarch 5, 2024 ...
(actemra), which targets il-6, a chemical your body makes that causes inflammation. your doctor will call this type of drug an "il-6 blocker." sometimes, biologic drugs will help you for a while and then don't work as well. it's not clear why. if it happens to you, tell your ...
There is significant development in the cancer pipeline, and according to Dr. Tharaldson, half of the specialty pharmaceuticals in the entire pipeline are being developed for use in cancer. Many of the cancer drugs in the pipeline are administered orally. There are targeted therapies and vaccines ...
There is enough demand to allow builders to pass on those cost increases to buyers: The median price of single-family houses sold in November spiked 18.8% year-over-year and by 27.1% from two years ago to $416,900. That means, ...